1. 1ISG-009 Budget impact analysis of a natalizumab extended interval dosing regimen. (24th March 2020) Authors: Pierobon, E; Mastrogiacomo, A; Capano, F; Ielo, D Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1ISG-013 Budget impact analysis of lung cancer immunotherapy: a hospital perspective. (March 2019) Authors: Pierobon, E; Capano, F; Ielo, D Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CP-125 Evaluation of compliance and tolerability in treatment-naÏve patients suffering from idiopathic pulmonary fibrosis (IPF) and treated with pirfenidone. (24th March 2015) Authors: Capano, F; Lerda, C; Bandelli, G; Filieri, A; Albera, C; Ielo, D Journal: European journal of hospital pharmacy Issue: Volume 22(2015)Supplement 1 Page Start: A50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CP-133 A pharmacoeconomic evaluation in the therapy evolution setting of renal cell carcinoma. (14th February 2016) Authors: Capano, F; Filieri, A; Lerda, C; Buscaino, A; Ielo, D Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗